Abstract
Ectopic kidneys are reported to occur in 1 in 500 to 1 in 1200 of the general population and can be found anywhere from the pelvis to the thorax. Tc-99m methylene diphosphonate (MDP) is a widely used radiopharmaceutical for skeletal scintigraphy and is excreted through the kidneys. The authors present 3 situations in which uptake of Tc-99m MDP in kidneys located at ectopic sites (subsequently confirmed by Tc-99m DMSA scintigraphy) may cause misinterpretation of the bone scan.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
